Physician and Payer Perspectives on Emerging LABA/ICS Combinations in Asthma and COPD – Will New Treatments Differentiate Themselves from Advair and Symbicort? - On Demand

Based on our Physician & Payer Forum report entitled Physician and Payer Acceptance of Emerging Fixed-Dose Combination Inhalers for Asthma and COPD, Decision Resources is offering an exclusive webinar entitled Physician and Payer Perspectives on Emerging LABA/ICS Combinations in Asthma and COPD – Will New Treatments Differentiate Themselves from Advair and Symbicort? Because this webinar features major report findings, it is ONLY available to purchasers of this report.

This webinar was held on May 26, 2010. Contact us to learn how you can purchase this report and access a recorded playback of this event.

Click here to view the invite.